A comparison of the pharmacokinetics of the anticancer MET inhibitor foretinib free base tablet formulation to bisphosphate salt capsule formulation in patients with solid tumors. [electronic resource]
Producer: 20120508Description: 327-34 p. digitalISSN:- 1573-0646
- Administration, Oral
- Adult
- Aged
- Angiogenesis Inhibitors -- administration & dosage
- Anilides -- administration & dosage
- Area Under Curve
- Biological Availability
- Capsules
- Chemistry, Pharmaceutical
- Cross-Over Studies
- Diphosphates -- administration & dosage
- Drug Compounding
- Female
- Humans
- Least-Squares Analysis
- Male
- Middle Aged
- Neoplasms -- drug therapy
- Protein Kinase Inhibitors -- administration & dosage
- Proto-Oncogene Proteins c-met -- antagonists & inhibitors
- Quinolines -- administration & dosage
- Tablets
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase I; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.